Hebei Changshan Biochemical Pharmaceutical Co., Ltd. (SHE:300255)
48.72
+1.13 (2.37%)
Sep 8, 2025, 11:44 AM CST
SHE:300255 Revenue
Hebei Changshan Biochemical Pharmaceutical had revenue of 232.90M CNY in the quarter ending June 30, 2025, a decrease of -14.83%. This brings the company's revenue in the last twelve months to 954.64M, down -17.55% year-over-year. In the year 2024, Hebei Changshan Biochemical Pharmaceutical had annual revenue of 1.03B, down -26.92%.
Revenue (ttm)
954.64M
Revenue Growth
-17.55%
P/S Ratio
45.82
Revenue / Employee
761.28K
Employees
1,254
Market Cap
43.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.03B | -379.63M | -26.92% |
Dec 31, 2023 | 1.41B | -925.79M | -39.63% |
Jan 1, 2023 | 2.34B | -631.82M | -21.29% |
Jan 1, 2022 | 2.97B | 604.26M | 25.56% |
Dec 31, 2020 | 2.36B | 292.31M | 14.11% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Jiangsu Hengrui Medicine | 30.15B |
WuXi AppTec | 41.90B |
Shenzhen Mindray Bio-Medical Electronics | 32.94B |
Sichuan Biokin Pharmaceutical | 441.19M |
Zhangzhou Pientzehuang Pharmaceutical., | 10.52B |
Aier Eye Hospital Group | 21.94B |
Shanghai United Imaging Healthcare | 10.98B |
Yunnan Baiyao Group Co.,Ltd | 40.84B |